Autoimmune diabetes: How many steps for one disease?

Research in Immunology

Volumn 148, Issue 5, 1997, Pages 332-338

  Bach, J F ^a   Chatenoud, L ^a   Herbelin, A ^a   Gombert, J M ^a   Carnaud, C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INSULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; DIABETOGENESIS; DIAGNOSIS; DISEASE COURSE; HISTORY OF MEDICINE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030770798     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)87243-4     Document Type: Article

References (39)

1. Bach, J.F. (1994), Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev., 15, 516-542.
2. Baxter, A.G. & Mandel, T.E. (1991), Hemolytic anemia in non-obese diabetic mice. Eur. J. Immunol., 21, 2051-2055.
3. Bendelac, A. (1995), Mouse NK1+T cells. Curr. Opin. Immunol., 7, 367-374.
4. Bendelac, A., Boitard, C., Bach, J.F. & Carnaud, C. (1989), Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice. Eur. J. Immunol., 19, 611-616.
5. Bendelac, A., Carnaud, C., Boitard, C. & Bach, J.F. (1987), Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J. Exp. Med., 166, 823-832.
6. Bernard, N.F., Ertug, F. & Margolese, H. (1992), High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes, 41, 40-46.
7. Boitard, C., Yasunami, R., Dardenne, M. & Bach, J.F. (1989), T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med., 169, 1669-1680.
8. Brown, D.R., Fowell, D.J., Corry, D.B., Wynn, T.A., Moskowitz, N.H., Cheever, A.W., Locksley, R.M. & Reiner, S.L. (1996), Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med., 184, 1295-1304.
9. Campbell, I.L., Oxbrown, L., Koulmanda, M. & Harrison, L.C. (1988), IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J. Immunol., 140, 1111-1116.
10. Charlton, B., Bacelj, A., Slattery, R.M. & Mandel, T.E. (1989), Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes, 38, 441-447.
11. Chatenoud, L., Primo, J. & Bach, J.F. (1997), CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol., 158, 2947-2954.
12. Chatenoud, L., Thervet, E., Primo, J. & Bach, J.F. (1994), Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. natl. Acad. Sci. USA, 91, 123-127.
13. Dardenne, M., Lepault, F., Bendelac, A. & Bach, J.F. (1989), Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol., 19, 889-895.
14. Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Grosser, I., Bedossa, P. & bach, J.F. (1991), Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun., 4, 237-248.
15. Debussche, X., Lormeau, B., Boitard, C., Toublanc, M. & Assan, R. (1994), Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation. Diabete Metab., 20, 282-290.
16. Gazda, L.M., Charlton, B. & Lafferty, K.J. (1997), Diabetes results from a late change in the autoimmune response of NOD mice. J. Autoimmun., 10 (in press).
17. Gombert, J.M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C. & Bach, J.F. (1996), Early quantitative and functional deficiency of NK1(+)-like thymocytes in the NOD mouse. Eur. J. Immunol., 26, 2989-2998.
18. Hancock, W.W., Polanski, M., Zhang, J., Blogg, N. & Weiner, H.L. (1995), Suppression of insulitis in nonobese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol., 147, 1193-1199.
19. Hayward, A.R. & Shreiber, M. (1989), Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J. Immunol., 143, 1555-1559.
20. Humphreys-Beher, M.G., Brinkley, L., Purushotham, K.R., Wang, P.L., Nakagawa, Y., Dusek, D., Kerr, M., Chegini, N. & Chan, E.K. (1993), Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice. Clin. Immunol. Immunopathol, 68, 350-356.
21. Itoh, A. & Maki, T. (1996), Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. Proc. Natl. Acad. Sci. USA, 93, 11053-11056.
22. Kaiserlian, D., Dardenne, M. & Bach, J.F. (1981), Dissociated effects of thymectomy at weaning on T-cell-mediated responses in vitro: correction by the serum thymic factor, FTS, and its analogs. Cell. Immunol., 64,93-101.
23. Katz, J.D., Wang, B., Haskins, K., Benoist, C. & Mathis, D. (1993), Following a diabetogenic T cell from genesis through pathogenesis. Cell, 74, 1089-1100.
24. Kawamura, T., Nagata, M., Utsugi, T. & Yoon, J.W. (1993), Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. J. Immunol., 151, 4362-4370.
25. Mieza, M.A., Itoh, T., Cui, J.Q., Makino, Y., Kawano, T., Tsuchida, K., Koike, T., Shirai, T., Yagita, H., Matsuzawa, A., Koseki, H. & Taniguchi, M. (1996), Selective reduction of V alpha 14(+) NK T cells associated with disease development in autoimmuneprone mice. J. Immunol., 156, 4035-4040.
26. Mueller, R., Krahl, T. & Sarvetnick, N. (1996), Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 184, 1093-1099.
27. Orlow, S., Yasunami, R., Boitard, C. & Bach, J.F. (1987), Induction précoce du diabète chez la souris NOD par la streptozotocine. C. R. Acad. Sci. III, 304, 77-78.
28. Pankewycz, O., Strom, T.B. & Rubin-Kelley, V.E. (1991), Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur. J. Immunol., 21, 873-879.
29. Pennline, K.J., Roque-Gaffney, E. & Monahan, M. (1994), Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol., 71, 169-175.
30. Rapoport, M.J., Jaramillo, A., Zipris, D., Lazarus, A.H., Serreze, D.V., Leiter, E.H., Cyopick, P., Danska, J.S. & Delovitch, T.L. (1993), Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87-99.
31. Rothe, H., Burkart, V., Faust, A. & Kolb, H. (1996), Interleudin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia, 39, 119-122.
32. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. (1995), Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151-1164.
33. Sempe, P., Bedossa, P., Richard, M.F., Villa, M.C., Bach, J.F. & Boitard, C. (1991), Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur. J. Immunol., 21, 1163-1169.
34. Sempe, P., Richard, M.F., Bach, J.F. & Boitard, C. (1994), Evidence of CD4+ regulatory T cells in the nonobese diabetic male mouse. Diabetologia, 37, 337-343.
35. Strandeil, E., Eizirik, D.L. & Sandler, S. (1990), Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. J. Clin. Invest., 85, 1944-1950.
36. Takeda, K. & Dennert, G. (1993), The development of autoimmunity in C57BL/6 Ipr mice correlates with the disappearance of natural killer type 1 positive cells. J. Exp. Med., 177, 155-164.
37. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K. & Adorini, L. (1995), Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817-821.
38. Yasunami, R. & Bach, J.F. (1988), Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol., 18, 481-484.
39. Zhang, Y., Rogers, K.H. & Lewis, D.B. (1996), Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med., 184, 1507-1512.